PRESS RELEASE published on 04/09/2025 at 18:45, 1 year 6 months ago EUROPLASMA: Précisions dans le cadre du projet de reprise de la Fonderie de Bretagne Europlasma précise l'offre de reprise de la Fonderie de Bretagne en redressement judiciaire. Report possible de la publication des résultats annuels 2024 Résultats Annuels Europlasma Reprise Redressement Judiciaire Fonderie De Bretagne
BRIEF published on 04/07/2025 at 18:05, 1 year 7 months ago Europlasma : Tirage d'une neufième tranche d'obligations convertibles Obligations Convertibles Europlasma Dépollution Croissance Industrielle Risque Dilution
BRIEF published on 04/07/2025 at 18:05, 1 year 7 months ago Europlasma: Drawing of a ninth tranche of convertible bonds Convertible Bonds Europlasma Decontamination Industrial Growth Dilution Risk
PRESS RELEASE published on 04/07/2025 at 18:00, 1 year 7 months ago EUROPLASMA: EXERCICE DU QUATRIÈME INVESTOR CALL Europlasma annonce le tirage de la neuvième tranche d'obligations convertibles en actions pour financer la croissance. Détails du financement et risques associés disponibles Croissance Financement Obligations Convertibles Europlasma Risques
BRIEF published on 04/04/2025 at 18:48, 1 year 7 months ago EUROPLASMA: Données sur le Capital et les Droits de Vote au 31 Mars 2025 Droits De Vote Capital Social Actions Europlasma Mars 2025
BRIEF published on 04/04/2025 at 18:48, 1 year 7 months ago EUROPLASMA: Data on Capital and Voting Rights as of March 31, 2025 Share Capital Voting Rights Actions Europlasma March 2025
PRESS RELEASE published on 04/04/2025 at 18:43, 1 year 7 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2025 EUROPLASMA publie le nombre total de droits de vote et d'actions au 31 mars 2025. Détails des activités du groupe dans la défense et l'environnement Capital Droits De Vote Europlasma Environnement Defense
BRIEF published on 04/04/2025 at 15:00, 1 year 7 months ago EUROPLASMA : Informations sur les droits de vote et actions en capital Droits De Vote Capital Social Europlasma Euronext Growth Actions En Circulation
BRIEF published on 04/04/2025 at 15:00, 1 year 7 months ago EUROPLASMA: Information on voting rights and capital shares Share Capital Voting Rights Europlasma Euronext Growth Shares Outstanding
BRIEF published on 04/04/2025 at 14:59, 1 year 7 months ago EUROPLASMA : Bilan des droits de vote et actions au 31 mars 2025 Droits De Vote Capital Social Europlasma Euronext Growth Actions En Circulation
Published on 11/06/2026 at 22:15, 2 days 12 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 21 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 22 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 22 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 10:05, 42 minutes ago Reactive Technologies Appoints Former Hitachi Energy CEO Claudio Facchin as Board Chairman
Published on 11/09/2026 at 10:00, 47 minutes ago Deutsche Beteiligungs AG: Green Datahub data centres successfully sold
Published on 11/09/2026 at 09:30, 1 hour 17 minutes ago Shelly Group: Invitation to Earnings Webcast/Call on 11 November 2026 on Unaudited 9M 2026 Results
Published on 11/09/2026 at 09:00, 1 hour 47 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 10:32, 15 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 15 minutes ago Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 3 hours 47 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 3 hours 47 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 3 hours 47 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
